9. Stock-Based Compensation

The Company recorded no outstanding stock option activity for the three months ended March 31, 2020. As of March 31, 2020, the Company had 377  options exercisable and outstanding with a weighted average exercisable price of approximately $7,447. The weighted average remaining contractual life was 5.1  years as of March 31, 2020. The options hold no intrinsic value. Total stock-based compensation expense included in the condensed consolidated statements of operations was $0 thousand for the three months ended March 31, 2020. There was no significant unrecognized stock-based compensation as of March 31, 2020.